Oncologyanalytics.com Website Review

Oncology An*lytics is a leading technology-enabled service company providing health plans, providers, and patients with an evidence-based, an*lytics focused approach to utilization management that is purpose-built for oncology Today’s cancer treatments are varied, complicated and costly. By 2021, global cancer drug expenditures are expected to exceed $147 billion, driven primarily by availability and favorable reimbursement of new medicines. Oncology An*lytics provides the critical missing link for health plans by helping to manage the total cost of cancer care. By providing access to current, evidence-based, disease-specific an*lytics on all cancer types and treatment options, backed by board-certified oncology physicians and pharmacists, health plans are able to to provide their members with the ability to achieve the best possible outcomes. Improved outcomes are possible when treatment options are tailored to the unique needs of the patient. Ensuring that patients receive the optimal treatment that balances efficacy, toxicity and affordability lie at the heart of Oncology An*lytics’ mission. The Oncology An*lytics e-Prior Authorization platform is purpose-built for oncology to efficiently evaluate and approve high-quality and For complex and complicated patient cases, the Oncology An*lytics’ Clinical Team facilitates peer-to-peer reviews in which the efficacy of the recommended cancer treatment is always prioritized over the cost of therapy. Oncology An*lytics offers de*p insights and an*lytics for health plans and providers, helping to drive further development and improvement of Accelerate Patient-First Oncology Benefits Management read more Move Designed to Accommodate Company’s Rapid Growth read more. HEALTHPARTNERS COLLABORATES WITH ONCOLOGY AN*LYTICS TO SUPPORT HIGH-COST CANCER TREATMENT. About Oncology An*lytics Oncology An*lytics, Inc. provides health plans with an evidence-based, technologically driven approach to utilization management, which is purpose-built for oncology.